Literature DB >> 26613872

Functional MR Imaging Techniques in Oncology in the Era of Personalized Medicine.

Matthias R Benz1, Hebert Alberto Vargas2, Evis Sala2.   

Abstract

DW and DCE MR imaging contribute significantly to diagnosis, treatment planning, response assessment, and prognosis in personalized cancer medicine. Nevertheless, the need for further standardization of these techniques needs to be addressed. Whole-body DW MR imaging is an exciting field; however, future studies need to investigate in more depth the biologic significance of the findings depicted, their prognostic relevance, and cost-effectiveness in comparison with MDCT and PET/CT. New MR imaging probes, such as targeted or activatable contrast agents and dynamic nuclear hyperpolarization, show great promise to further improve the care of patients with cancer in the near future.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DCE; DNP; DWI; Hepatobiliary contrast agent; MRS; SPIO

Mesh:

Substances:

Year:  2015        PMID: 26613872      PMCID: PMC5031083          DOI: 10.1016/j.mric.2015.08.001

Source DB:  PubMed          Journal:  Magn Reson Imaging Clin N Am        ISSN: 1064-9689            Impact factor:   2.266


  72 in total

1.  Short- and midterm reproducibility of apparent diffusion coefficient measurements at 3.0-T diffusion-weighted imaging of the abdomen.

Authors:  Adam C Braithwaite; Brian M Dale; Daniel T Boll; Elmar M Merkle
Journal:  Radiology       Date:  2008-12-18       Impact factor: 11.105

2.  Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.

Authors:  Katja Pinker; Wolfgang Bogner; Pascal Baltzer; Stephan Gruber; Hubert Bickel; Benedikt Brueck; Siegfried Trattnig; Michael Weber; Peter Dubsky; Zsuzsanna Bago-Horvath; Rupert Bartsch; Thomas H Helbich
Journal:  Invest Radiol       Date:  2014-06       Impact factor: 6.016

3.  Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer.

Authors:  M J Gollub; D H Gultekin; O Akin; R K Do; J L Fuqua; M Gonen; D Kuk; M Weiser; L Saltz; D Schrag; K Goodman; P Paty; J Guillem; G M Nash; L Temple; J Shia; L H Schwartz
Journal:  Eur Radiol       Date:  2011-11-20       Impact factor: 5.315

4.  Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy.

Authors:  F Parivar; H Hricak; K Shinohara; J Kurhanewicz; D B Vigneron; S J Nelson; P R Carroll
Journal:  Urology       Date:  1996-10       Impact factor: 2.649

5.  Dynamic Contrast-enhanced MR Imaging Curve-type Analysis: Is It Helpful in the Differentiation of Prostate Cancer from Healthy Peripheral Zone?

Authors:  Barry G Hansford; Yahui Peng; Yulei Jiang; Michael W Vannier; Tatjana Antic; Stephen Thomas; Stephanie McCann; Aytekin Oto
Journal:  Radiology       Date:  2015-01-05       Impact factor: 11.105

6.  [Evaluation of magnetic resonance signal intensity in bone marrow after administration of super paramagnetic iron oxide (SPIO)].

Authors:  Noriko Kotoura; Kiyoshi Sakamoto; Yuko Fukuda; Reiichi Ishikura; Takuya Enoki; Tatsuya Yamashita; Yasuo Nakae
Journal:  Nihon Hoshasen Gijutsu Gakkai Zasshi       Date:  2011

7.  Comparison of gadobenate dimeglumine with gadopentetate dimeglumine for magnetic resonance imaging of liver tumors.

Authors:  R Kuwatsuru; M Kadoya; K Ohtomo; A Tanimoto; S Hirohashi; T Murakami; Y Tanaka; K Yoshikawa; H Katayama
Journal:  Invest Radiol       Date:  2001-11       Impact factor: 6.016

8.  Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy.

Authors:  Sam E Day; Mikko I Kettunen; Ferdia A Gallagher; De-En Hu; Mathilde Lerche; Jan Wolber; Klaes Golman; Jan Henrik Ardenkjaer-Larsen; Kevin M Brindle
Journal:  Nat Med       Date:  2007-10-28       Impact factor: 53.440

Review 9.  MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA.

Authors:  Christoph J Zech; Karin A Herrmann; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Magn Reson Med Sci       Date:  2007       Impact factor: 2.471

10.  Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme.

Authors:  Pascal O Zinn; Bhanu Mahajan; Bhanu Majadan; Pratheesh Sathyan; Sanjay K Singh; Sadhan Majumder; Ferenc A Jolesz; Rivka R Colen
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

View more
  1 in total

1.  Combing MRI Perfusion and 18F-FDG PET/CT Metabolic Biomarkers Helps Predict Survival in Advanced Nasopharyngeal Carcinoma: A Prospective Multimodal Imaging Study.

Authors:  Sheng-Chieh Chan; Chih-Hua Yeh; Joseph Tung-Chieh Chang; Kai-Ping Chang; Jen-Hung Wang; Shu-Hang Ng
Journal:  Cancers (Basel)       Date:  2021-03-28       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.